La Jolla Pharmaceutical Company Announced an Exclusive Licensing Agreement for GIAPREZA and XERAVA La Jolla Pharmaceutical Company (LJPC) announced today in a press release that . . . This content is for paid subscribers. Please click here to subscribe or here to log in.

COVID-19, The Market Rebounding and the Biotech Firms That Did and Didn't Rally The Market Rebounding included: Amgen (AMGN), Biogen (